Christiana Stamoulis's Net Worth
$35.4 Million
Who is Christiana Stamoulis?
Christiana Stamoulis has an estimated net worth of $35.4 Million. This is based on reported shares across multiple companies, which include VERTEX PHARMACEUTICALS INC / MA, HOLOGIC INC, INCYTE CORP, and Unum Therapeutics Inc..
SEC CIK
Christiana Stamoulis's CIK is 0001502917
Past Insider Trading and Trends
2013 was Christiana Stamoulis's most active year for acquiring shares with 10 total transactions. Christiana Stamoulis's most active month to acquire stocks was the month of February. 2013 was Christiana Stamoulis's most active year for disposing of shares, totalling 14 transactions. Christiana Stamoulis's most active month to dispose stocks was the month of June. 2013 saw Christiana Stamoulis paying a total of $2,887,357.50 for 183,906 shares, this is the most they've acquired in one year. In 2013 Christiana Stamoulis cashed out on 173,226 shares for a total of $7,124,536.72, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
VERTEX PHARMACEUTICALS INC / MA (VRTX) Snapshot price: $468
SVP, Corp Strategy & Bus Devlp
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 30
| |||
Form 4
|
—
|
0
|
$60.08 | -$59,091.75 | 40.71K |
Scheduled
|
Jul 15
| ||
Form 4
|
—
|
0
|
$57.89 | -$218,584.95 | 40.71K |
Scheduled
|
Jul 5
| ||
Form 4
| -1.46% | -602.00 |
$79.65 | -$47,948.96 | 40.71K |
Scheduled
|
May 15
| ||
Form 4
| -10.94% | -5.00K |
$56.98 | -$3,911,655.22 | 40.71K |
Scheduled
|
Apr 29 - Apr 30
| ||
Form 4
| +28.60% | 10.17K |
$0.01 | $101.66 | 45.71K |
Feb 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 25
| |||
Form 4
| +41.42% | 10.17K |
$0.01 | $101.66 | 34.71K |
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 13
| |||
Form 4
| +74.49% | 10.17K |
$0.01 | $101.66 | 23.81K |
Feb 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HOLOGIC INC (HOLX) Snapshot price: $81.57
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$53.12 | -$476,897.64 | 45.47K |
Scheduled
|
Jul 17
| ||
Form 4
| +3.58% | 1.57K |
—
|
—
| 45.47K |
Mar 7
| |||
Form 4
| +3.45% | 1.47K |
—
|
—
| 43.9K |
Mar 9
| |||
Form 4
| +3.83% | 1.56K |
—
|
—
| 42.44K |
Mar 10
| |||
Form 4
| +3.75% | 1.48K |
—
|
—
| 40.87K |
Mar 11
| |||
Form 4
|
—
|
0
|
$48.18 | -$575,690.90 | 39.39K |
Scheduled
|
Nov 4
| ||
Form 4
| +5.96% | 2.22K |
—
|
—
| 39.39K |
Mar 5
| |||
Form 4
|
—
|
0
|
$34.88 | -$365,980.44 | 37.17K |
Nov 22
| |||
Form 4
| +6.10% | 2.14K |
—
|
—
| 37.17K |
Mar 7
| |||
Form 4
|
—
|
0
|
$31.01 | -$357,819.69 | 35.04K |
Scheduled
|
Nov 28
| ||
Form 4
|
—
|
0
|
$28.00 | -$786,995.34 | 35.04K |
Scheduled
|
Oct 2
| ||
Form 4
| +7.37% | 2.41K |
—
|
—
| 35.04K |
Mar 14
| |||
Form 4
| +16.55% | 4.63K |
—
|
—
| 32.63K |
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
| +13.23% | 3.27K |
—
|
—
| 28K |
Jan 1
| |||
Form 4
| +18.80% | 3.91K |
$26.74 | $104,660.36 | 24.73K |
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
| +26.59% | 4.37K |
—
|
—
| 20.81K |
Jan 1
| |||
Form 4
| +43.66% | 5K |
—
|
—
| 16.44K |
Jan 1
| |||
Form 4
|
∞
| 11.45K |
—
|
—
| 11.45K |
Nov 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INCYTE CORP (INCY) Snapshot price: $60.96
EVP & Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +13.91% | 11.62K |
$64.25 | -$60,909.00 | 95.2K |
Jul 15
| |||
Form 4
| -7.60% | -6.87K |
$59.02 | -$405,467.40 | 83.57K |
Jul 2
| |||
Form 4
| +8.93% | 7.38K |
—
|
—
| 89.98K |
Feb 14
| |||
Form 4
| -0.47% | -387.00 |
$57.84 | -$22,384.08 | 82.61K |
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
| +17.31% | 12.25K |
—
|
—
| 82.99K |
Jul 14
| |||
Form 4
| -7.91% | -6.07K |
$62.08 | -$377,011.84 | 70.75K |
Jul 3
| |||
Form 4
| -1.52% | -1.18K |
$80.08 | -$94,414.32 | 76.46K |
Feb 13
| |||
Form 4
| +6.85% | 4.98K |
—
|
—
| 77.64K |
Jan 20
| |||
Form 4
| +28.68% | 16.19K |
$79.25 | -$89,077.00 | 72.66K |
Jul 2 - Jul 5
| |||
Form 4
| -2.05% | -1.18K |
$66.76 | -$78,576.52 | 56.28K |
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
| +33.64% | 14.46K |
—
|
—
| 57.46K |
Jan 1
| |||
Form 4
| +6.79% | 2.73K |
—
|
—
| 43K |
Nov 19
| |||
Form 4
| +22.28% | 7.34K |
—
|
—
| 40.27K |
Jul 2
| |||
Form 4
| -3.58% | -1.21K |
$84.99 | -$102,837.90 | 32.61K |
Feb 11
| |||
Form 4
| +51.67% | 11.52K |
—
|
—
| 33.82K |
Jan 15
| |||
Form 4
| +5.85% | 1.23K |
—
|
—
| 22.3K |
Nov 16
| |||
Form 4
| +46.24% | 6.66K |
—
|
—
| 21.07K |
Jul 2
| |||
Form 4
| +32.90% | 3.49K |
$76.14 | $265,576.32 | 14.09K |
Feb 11
| |||
Form 4
|
∞
| 10.29K |
$80.21 | $824,959.85 | 10.29K |
Feb 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Unum Therapeutics Inc. (COGT) Snapshot price: $10.47
President & C.F.O.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||